Newsroom | 19080 results

CHICAGO & SAN FRANCISCO & REMOTE-FIRST COMPANY--(BUSINESS WIRE)--Madison Dearborn Partners to Acquire Significant Ownership Position in NextGen Healthcare...

DUBLIN--(BUSINESS WIRE)--The "Medical Imaging Market" report has been added to ResearchAndMarkets.com's offering. The Medical Imaging Market was valued at USD 63.4 billion in 2024, and is projected to reach USD 82.6 billion by 2029, rising at a CAGR of 5.50%. Report Scope This research report comprehensively analyzes the medical imaging market, including forecasts and sales projections through 2029. The report provides an overview of product types, including X-ray systems, ultrasound devices, m...

MONTREAL--(BUSINESS WIRE)--Pathway today announced that its proprietary large-language model (LLM) scored 96% on a validated set of United States Medical Licensing Examination (USMLE) questions, the highest accuracy yet reported for a specialized medical AI. The result strengthens Pathway’s position as a leading evidence-based decision-support tool for frontline clinicians. In head-to-head testing, Pathway’s “Deep” AI model surpassed domain-specific peers MediSearch Pro, OpenEvidence and Hippoc...

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Bardavon, a leading national PT/OT network serving the workers’ compensation industry, is proud to announce the promotion of Sarah Meyer to Chief Operating Officer (COO). Meyer has been with Bardavon since 2017, most recently serving as Senior Vice President of Client Experience & Network Expansion, where she played a critical role in strengthening the company's provider and payor relationships. Sarah began her tenure at Bardavon as Director of Provider...

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced an intended expansion of its radiation oncology portfolio as well as the introduction of the new AI-enabled MR Contour DL™ at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2025 Congress in Vienna, Austria. The company will also showcase its updated Intelligent Radiation Therapy (iRT), a software solution that standardizes complex workflows, helping to enable a shorter timeline from diagnosis to treatmen...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), a social innovation platform accelerating promising health innovations, announced that Aditxt’s CIO Dr. Shahrokh Shabahang, and Adimune’s Co-CEO Dr. Friedrich Kapp, will join today’s Aditxt Weekly Update to discuss recent developments related to ADI-100™, the lead therapeutic candidate of its wholly owned subsidiary, Adimune. Event Details: Title: Aditxt Weekly Update Date: Friday, May 2, 2025 Time:...

DUBLIN--(BUSINESS WIRE)--The "Masterclass: Market Authorisation of AI-enabled Medical Devices Training Course" conference has been added to ResearchAndMarkets.com's offering. Join this course to gain a solid understanding of the legislative landscape, enabling you to shape your use cases and secure a prosperous future for your AI initiatives. It is challenging to keep up with the rapidly changing regulations applicable to AI-based medical devices. Many AI providers face regulatory, implementati...

DUBLIN--(BUSINESS WIRE)--The "Lab-on-a-Chip and Microfluidics Europe 2025" conference has been added to ResearchAndMarkets.com's offering. The Lab-on-a-Chip and Microfluidics Europe 2025 now in its 17th year brings together researchers and industry participants from both academia and industry focusing on technology and innovation in the Lab-on-a-Chip (LOAC) and Microfluidics fields. Presentations will explore the latest advances in the Lab-on-a-Chip and Microfluidics Fields. Focus at this confe...

サンディエゴ--(BUSINESS WIRE)--（ビジネスワイヤ） -- 米国に本社を置き、JSRライフサイエンスおよび日本に本社を置くJSR株式会社傘下のグローバルCRO（開発業務受託機関）であるCrown Bioscienceは、世界最大級のフェーズIオンコロジー臨床試験ネットワークの一つであるNEXT Oncologyとの提携を延長することを発表いたします。この戦略的提携により、Crown Bioscienceの臨床的に意義のあるがんオルガノイドおよび患者由来異種移植（PDX）モデルの開発における豊富な経験と、NEXT Oncologyのグローバルな臨床ネットワークおよびフェーズI臨床試験の専門知識を、引き続き活用していくことになります。 この契約延長により、Crown Bioscienceは、NEXT Oncologyの業界をリードするグローバル臨床試験ネットワークから提供される患者サンプルに基づくサービスを提供する独占的権利を再確認します。この提携は、トランスレーショナル・オンコロジー研究において、臨床的に最も関連性の高いPDXおよびオルガノイドモデルとソリューションを提...

TRONDHEIM, Norvège--(BUSINESS WIRE)--Vespa.ai, la plateforme d'applications d'IA à grande échelle et en temps réel alimentée par le big data, annonce aujourd'hui la nomination de Harini Gopalakrishnan au poste de directeur général de la santé et des sciences du vivant. M. Gopalakrishnan, anciennement CTO pour les sciences du vivant chez Snowflake, mènera des initiatives stratégiques de Vespa dans ce secteur. Vespa.ai fournit l'infrastructure nécessaire à la création et au déploiement d'applicat...